Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 12Solid Tumor 5Nasopharyngeal Carcinoma 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 3Melanoma 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Sarcoma 2Recurrence 2Neoplasms 2Locally Advanced or Metastatic Solid Tumors 2Liposarcoma 2Advanced Solid Tumors 2Advanced Lung Cancer 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor, Adult 1Solid Cancer 1Small Cell Lung Carcinoma 1Pyloric Stenosis, Hypertrophic 1Pancreatic Neoplasms 1Pancreatic Cancer Metastatic 1PD-1 1Ovarian Neoplasms 1Meningeal Carcinomatosis 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Leiomyosarcoma 1

Interventions

pembrolizumab 3toripalimab 1spartalizumab 1sotorasib 1pazopanib 1palbociclib 1abemaciclib 1Trastuzumab 1Therapeutics 1Jupiter 1Interleukin-2 1Immune Checkpoint Inhibitors 1Fulvestrant 1EBI-005 1Cetuximab 1Catalytic Domain 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Solid Tumor, Adult × toripalimab × Clear all
NCT06088004 2025-08-22

Phase â… /â…¡ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Suzhou Abogen Biosciences Co., Ltd.

Phase 1/2 Recruiting
218 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡